You have 9 free searches left this month | for more free features.

Condition

Malaria (2)

Acute Uncomplicated Plasmodium Falciparum Malaria (1)

Uncomplicated Plasmodium Falciparum Malaria (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 2 (3)

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (4)

Collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP) (1)

Medicines for Malaria Venture (1)

Intervention

kaf156 (4)

coartem (1)

lum-sdf (1)

lumefantrine solid dispersion formulation (1)

placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

kaf156

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Uncomplicated Plasmodium Falciparum Malaria Trial in Burkina Faso, Gabon, Mali (KAF156, LUM-SDF)

Recruiting

Uncomplicated Plasmodium Falciparum Malaria

KAF156
LUM-SDF

Bobo Dioulasso, Burkina Faso
+4 more

Jun 20, 2022

Acute Uncomplicated Plasmodium Falciparum Malaria Trial in Worldwide (KAF156, Coartem, Lumefantrine Solid Dispersion

Completed

Has Results

Acute Uncomplicated Plasmodium Falciparum Malaria

KAF156
+2 more

Nanoro, Burkina Faso
+10 more

Dec 21, 2021

Malaria Trial in Seattle (KAF156, Placebo)

Completed

Malaria

KAF156
Placebo

Seattle, Washington

Novartis Investigative Site

Aug 26, 2019

Malaria Trial in Thailand, Vietnam (KAF156)

Completed

Has Results

Malaria

KAF156

Bangkok, Thailand
+4 more

Jun 4, 2018